Experta Medica Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-12-2024
- Paid Up Capital ₹ 2.00 M
as on 03-12-2024
- Company Age 46 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 7.07%
(FY 2021)
- Profit 24.97%
(FY 2021)
- Ebitda 15.81%
(FY 2021)
- Net Worth 15.07%
(FY 2021)
- Total Assets -6.57%
(FY 2021)
About Experta Medica
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dikshant Sharma, Prashant Sharma, and Yugank Dikshant serve as directors at the Company.
- CIN/LLPIN
U24232RJ1978PTC001796
- Company No.
001796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 1978
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- LocationJaipur, Rajasthan
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Experta Medica?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yugank Dikshant  | Director | 27-Apr-2017 | Current |
| Dikshant Sharma | Director | 01-Oct-2021 | Current |
| Prashant Sharma | Director | 01-Oct-2021 | Current |
Financial Performance of Experta Medica.
Experta Medica Pvt Ltd, for the financial year ended 2021, experienced modest growth in revenue, with a 7.07% increase. The company also saw a substantial improvement in profitability, with a 24.97% increase in profit. The company's net worth Soared by an impressive increase of 15.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Experta Medica?
In 2021, Experta Medica had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Health Colonies And Construction Private LimitedActive 73 years 2 monthsDikshant Sharma, Prashant Sharma and 1 more are mutual person
- Builders Alliance Private LimitedActive 32 years 11 months
Dikshant Sharma, Prashant Sharma and 1 more are mutual person
- H Chandra Private LimitedActive 72 years 3 months
Dikshant Sharma and Prashant Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Experta Medica?
Unlock and access historical data on people associated with Experta Medica, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Experta Medica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Experta Medica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
